| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK3R6 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | GYPA | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | CSF2RB | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | IRAK3 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PTGER3 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ALAS2 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | TBATA | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | FCER1A | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | RNASE6 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | CD4 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
